查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827777

2025年RNA分析与转录组学全球市场报告

RNA Analysis/ Transcriptomics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，RNA分析和转录组学市场快速扩张，从2024年的77.2亿美元成长到2025年的87.4亿美元，复合年增长率为13.3%。预测期内的成长归因于癌症研究和精准医疗、药物研发、感染疾病诊断、个人化医疗、学术和政府资助以及农业领域不断扩展的应用。

预计未来几年 RNA 分析和转录组学市场将快速成长，到 2029 年将达到 163.1 亿美元，年复合成长率(CAGR)为 16.9%。预测期内的增长归因于单细胞 RNA 定序应用、RNA 分析在临床诊断中的整合、基于 RNA 的治疗方法和疫苗、生物资讯学和数据分析工具以及生物标记的发现和检验。预测期内的主要趋势包括空间转录组学和原位 RNA 分析、长读 RNA 定序技术、RNA 编辑和修饰分析、人工智慧在 RNA 数据分析中的整合、罕见疾病的 RNA 治疗方法以及用于癌症检测的基于 RNA 的液态切片。

转录组学，也称为 RNA 分析，是在特定背景、环境条件或特定细胞内使用复杂方法对转录组进行研究。

RNA分析和转录组学市场的主要产品类型包括试剂/耗材、仪器和软体。这些产品应用于临床诊断、药物研发、毒理基因体学、比较转录组学和RNA干扰等多个领域。 RNA分析和转录组学涉及的关键技术包括微阵列、定序、聚合酵素链锁反应和RNA干扰。在临床诊断中，RNA分析用于检测不同种类的RNA、病原体RNA、剪接变异体以及其他疾病诊断所需的元素。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供 RNA 分析和转录组学市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的 RNA 分析和转录组学细分市场、市场趋势和机会，以及您在 RNA 分析和转录组学行业取得成功所需的数据。这份 RNA 分析和转录组学市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长16.9%，较先前预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这种影响将透过对主要来自瑞士和新加坡的逆转录酶和次世代定序仪流动槽征收关税直接影响美国，从而提高基因组研究和诊断的成本。此外，由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

RNA分析和转录组学市场的成长预计将受到个人化医疗需求日益增长的推动，个人化医疗是指根据每位患者的个别特征量身定制治疗方案。 RNA定序技术非常适合管理与实施个人化医疗实践和流程相关的庞大临床工作量。个人化医疗联盟 (PMC) 于2022年10月报告称，将有超过75,000种基因检测产品和超过300种个人化药物可用于治疗各种疾病，包括多种癌症、罕见遗传疾病以及慢性病和感染疾病。个人化药物需求的激增是推动RNA分析市场成长的关键因素。

慢性病的日益普及预计将推动未来 RNA 分析和转录组学市场的扩张。慢性病是一种持续时间超过一年、干扰日常生活并需要持续医疗照护的疾病。在慢性病研究中使用 RNA 分析和转录组学可以加深对疾病机制的理解，从而实现更好的诊断并促进开发更有针对性和个性化的治疗性介入。例如，2022 年 9 月，总部位于瑞士的联合国专门机构世界卫生组织 (WHO) 报告称，非传染性疾病 (NCD) 或慢性病每年在全球造成 4,100 万人死亡，占所有死亡人数的 74%。其中，心血管疾病造成 1,790 万人死亡，癌症造成 930 万人死亡，慢性呼吸道疾病造成 410 万人死亡，糖尿病造成 200 万人死亡。因此，慢性病盛行率的上升正在推动 RNA 分析和转录组学市场的成长。

RNA分析和转录组学市场的一个新兴趋势是关注RNA分析的技术进步和创新。次世代定序仪（NGS）和RNA干扰（RNAi）等技术有助于提高转录活性分析的精确度和准确性。例如，Illumina开发的次世代定序仪成功地分割了DNA/RNA，创建了定序文库并组装进行了重组，从而增强了基因组序列分析。

RNA分析和转录组学市场的主要企业越来越注重推出创新产品组合，以获得竞争优势。 2023年5月，Twist Bioscience Corporation宣布推出一套全面的RNA定序工具，包括针对RNA和全转录组定序的标靶富集功能。此组合包含Twist RNA外显子组、Twist RNA文库製备试剂盒以及Twist核醣体RNA (rRNA)和血红蛋白(Globin)去除试剂盒等产品，描述了分析mRNA蛋白编码序列、客製化标靶和总RNA的完整工作流程。

策略伙伴关係和合作是RNA分析和转录组学市场主要企业关注的重点。此类合作通常涉及整合RNA文库製备试剂套件的专业知识，并整合不同机构的知识和资源。例如，Singular Genomics Systems Inc.于2022年1月与Lexogen合作，展示了其G4定序平台与Lexogen RNA研究产品的兼容性。此次合作旨在帮助客户将G4无缝整合到其现有的下一代定序(NGS)工作流程中。

参与 RNA 分析和转录组学市场的主要企业包括 Affymetrix Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、GE Healthcare、Illumina Inc.、QIAGEN NV、F. Hoffmann-La Roche Ltd.、Sigma-Aldrich Corporation、Thermo Fisher Scient Inc.、Fluxic Corporation Inc. SE、Merck KGaA、Pacific Biosciences of California Inc.、Danaher Corporation、Genewiz Inc.、Oxford Nanopore Technologies Ltd.、BGI Group 和 Genotypic Technology Pvt。 Ltd、Ltd.、MedGenome Labs Pvt.Ltd.、Xcelris Labs Ltd.、Ocimum Biosolutions Ltd.、Strand Life Sciences Pvt.Ltd.、SciGenom Labs Pvt.Ltd.、Oncocyte Corporation、Tempus Labs Inc.、ArcherDX Inc. 和 HTG Molec.

2024年，北美是RNA分析和转录组学市场最大的地区，预计在预测期内将成为成长最快的地区。 RNA分析和转录组学市场报告涵盖以下地区：亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

RNA 分析和转录组学市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

RNA分析和转录组学市场涵盖提供全基因组定序、全外EXOME定序、标靶定序、微阵列分析和桑格定序等服务的营业单位所产生的收益。市场规模包括服务供应商销售或包含在其服务产品中的相关商品的价值。仅包括企业之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球 RNA 分析和转录组学：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球 RNA 分析与转录组学市场：成长率分析
  • 全球 RNA 分析与转录组学市场表现：规模与成长，2019-2024 年
  • 全球 RNA 分析与转录组学市场预测：规模与成长，2024-2029 年，2034 年
  • 全球 RNA 分析与转录组学：总潜在市场 (TAM)

第六章 市场细分

  • 全球 RNA 分析和转录组学市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 试剂和耗材
  • 装置
  • 软体
  • 全球 RNA 分析和转录组学市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 微阵列
  • 顺序
  • 聚合酵素链锁反应/ RNA干扰
  • 全球 RNA 分析和转录组学市场的应用、表现和预测（2019-2024 年、2024-2029 年、2034 年）
  • 临床诊断
  • 药物研发
  • 毒理基因组学
  • 比较转录组学
  • RNA干扰
  • 全球 RNA 分析和转录组学市场：试剂和耗材细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 核苷酸
  • 酵素
  • 缓衝液和溶液
  • 样品製备套件
  • 定序试剂套件
  • 全球 RNA 分析和转录组学市场：仪器细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 序列器
  • 即时PCR设备
  • 微阵列
  • 电泳系统
  • 机器人液体处理器
  • 全球 RNA 分析与转录组学市场：软体细分、类型、表现和预测（2019-2024 年、2024-2029 年、2034 年）
  • 数据分析软体
  • 生物资讯学工具
  • 统计分析软体
  • 视觉化软体
  • 资料库管理系统

第七章 区域和国家分析

  • 全球 RNA 分析与转录组学市场：区域表现与预测（2019-2024 年、2024-2029 年和 2034 年）
  • 全球 RNA 分析与转录组学市场：按国家、地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • RNA分析与转录组学市场：竞争格局
  • RNA分析与转录组学市场：公司简介
    • Affymetrix Inc.
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • GE Healthcare
    • Illumina Inc.

第31章：其他领先和创新企业

  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Fluidigm Corporation
  • Promega Corporation
  • bioMerieux SA
  • CD Genomics Inc.
  • Eurofins Scientific SE
  • Merck KGaA
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Genewiz Inc.
  • Oxford Nanopore Technologies Ltd.
  • BGI Group

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年 RNA 分析与转录组学市场：提供新机会的国家
  • 2029 年 RNA 分析与转录组学市场：细分领域将带来新机会
  • RNA分析与转录组学市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22038u

Transcriptomics, also known as RNA analysis, is the study of the transcriptome under specific circumstances, environmental conditions, or within specific cells using high-throughput methods.

The main product categories in the RNA analysis/transcriptomics market include reagents/consumables, instruments, and software. These products find applications in various fields, such as clinical diagnostics, drug discovery, toxicogenomics, comparative transcriptomics, and RNA interference. The major technologies involved in RNA analysis/transcriptomics are microarrays, sequencing, polymerase chain reaction, and RNA interference. In clinical diagnostics, RNA analysis is employed to detect different RNA species, pathogen RNA, splice variants, and other elements crucial for disease diagnosis.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The RNA analysis/ transcriptomics market research report is one of a series of new reports from The Business Research Company that provides RNA analysis/ transcriptomics market statistics, including RNA analysis/ transcriptomics industry global market size, regional shares, competitors with a RNA analysis/ transcriptomics market share, detailed RNA analysis/ transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the RNA analysis/ transcriptomics industry. This RNA analysis/ transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rna analysis/ transcriptomics market size has grown rapidly in recent years. It will grow from $7.72 billion in 2024 to $8.74 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to cancer research and precision medicine, drug discovery and development, infectious disease diagnostics, personalized medicine, academic and government funding, growing applications in agriculture.

The rna analysis/ transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $16.31 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to single-cell rna sequencing applications, integration of rna analysis in clinical diagnostics, rna-basedTherapies and vaccines, bioinformatics and data analysis tools, biomarker discovery and validation. Major trends in the forecast period include spatial transcriptomics and in situ rna analysis, long-read rna sequencing technologies, rna editing and modification analysis, integration of ai in rna data analysis, rna therapeutics for rare diseases, rna-based liquid biopsy for cancer detection.

The forecast of 16.9% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on reverse transcriptase enzymes and next-generation sequencing flow cells, largely sourced from Switzerland and Singapore, raising expenses for genomic research and diagnostics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the RNA analysis/transcriptomics market is anticipated to be driven by the increasing demand for personalized medicine. Personalized medicine involves tailoring medical treatment to the unique characteristics of each patient. The RNA-Seq technology is well-suited to manage the substantial clinical workload associated with implementing personalized clinical care practices and processes. The Personalized Medicine Coalition (PMC) reported in October 2022 that there will be over 75,000 genetic testing products and 300 personalized medicines available for various conditions such as multiple types of cancer, genetic rare diseases, and chronic and infectious diseases. This surge in demand for personalized medicines is a key factor propelling the growth of the RNA analysis market.

The growing prevalence of chronic diseases is expected to drive the expansion of the RNA analysis/transcriptomics market in the future. Chronic diseases are defined as conditions lasting a year or longer that hinder daily activities and necessitate ongoing medical care. The use of RNA analysis and transcriptomics in chronic disease research enhances understanding of disease mechanisms, leads to better diagnostics, and facilitates the development of more targeted and personalized therapeutic interventions. For instance, in September 2022, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths each year, accounting for 74% of deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur globally. Among these, there were 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rising incidence of chronic diseases is propelling the growth of the RNA analysis/transcriptomics market.

An emerging trend in the RNA analysis/transcriptomics market is the focus on technological advancements and innovations in RNA analysis. Next-generation sequencing (NGS) and RNA interference (RNAi) are among the technologies contributing to improved precision and accuracy in analyzing transcriptional activity. Illumina's development of Next-generation sequencing, for example, has proven successful in fragmenting DNA/RNA, sequencing libraries, and reassembling them, enhancing genomic sequence analysis.

Major companies in the RNA analysis/transcriptomics market are increasingly emphasizing the introduction of innovative portfolios to gain a competitive advantage. Twist Bioscience Corporation, in May 2023, launched a comprehensive RNA sequencing tools portfolio, including specific target enrichment capabilities for RNA and whole transcriptome sequencing. The portfolio comprises products such as the Twist RNA Exome, Twist RNA Library Prep Kit, and Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit, offering complete workflows for analyzing mRNA protein coding sequences, custom targets, and total RNA.

Strategic partnerships and collaborations are a significant focus for major companies in the RNA analysis/transcriptomics market. These partnerships often involve integrating expertise in RNA library preparation kits, combining the knowledge and resources of different organizations. For instance, Singular Genomics Systems Inc. collaborated with Lexogen in January 2022 to demonstrate the compatibility of the G4 sequencing platform with Lexogen's products for RNA research. This partnership aims to provide customers with a seamless integration of the G4 into existing Next-Generation Sequencing (NGS) workflows.

Major companies operating in the RNA analysis/ transcriptomics market include Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMerieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.

North America was the largest region in the RNA analysis/transcriptomics market in 2024. This region is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA analysis/ transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the RNA analysis/ transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The RNA analysis/ transcriptomics market includes revenues earned by entities by providing services such as Whole-Genome Sequencing, Whole-Exome Sequencing, Targeted Sequencing, Microarray Analysis, Sanger Sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

RNA Analysis/ Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rna analysis/ transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rna analysis/ transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rna analysis/ transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents/Consumables; Instruments; Software

2) By Technology; Microarrays; Sequencing; Polymerase Chain Reaction RNA Interference

  • 3) By Application: Clinical Diagnostics; Drug Discovery; Toxicogenomics; Comparative Transcriptomics; RNA Interference
  • Subsegments:
  • 1) By Reagents/Consumables: Nucleotides; Enzymes; Buffers and Solutions; Sample Preparation Kits; Sequencing Kits
  • 2) By Instruments: Sequencers; Real-Time PCR Machines; Microarrays; Electrophoresis Systems; Robotic Liquid Handlers
  • 3) By Software: Data Analysis Software; Bioinformatics Tools; Statistical Analysis Software; Visualization Software; Database Management Systems
  • Companies Mentioned: Affymetrix Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; GE Healthcare; Illumina Inc.; QIAGEN N.V.; F. Hoffmann-La Roche Ltd.; Sigma-Aldrich Corporation; Thermo Fisher Scientific Inc.; Fluidigm Corporation; Promega Corporation; bioMerieux S.A.; CD Genomics Inc.; Eurofins Scientific SE; Merck KGaA; Pacific Biosciences of California Inc.; Danaher Corporation; Genewiz Inc.; Oxford Nanopore Technologies Ltd.; BGI Group; Genotypic Technology Pvt. Ltd.; MedGenome Labs Pvt. Ltd.; Xcelris Labs Ltd.; Ocimum Biosolutions Ltd.; Strand Life Sciences Pvt. Ltd.; SciGenom Labs Pvt. Ltd.; Oncocyte Corporation; Tempus Labs Inc.; ArcherDX Inc.; HTG Molecular Diagnostics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. RNA Analysis/ Transcriptomics Market Characteristics

3. RNA Analysis/ Transcriptomics Market Trends And Strategies

4. RNA Analysis/ Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global RNA Analysis/ Transcriptomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global RNA Analysis/ Transcriptomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global RNA Analysis/ Transcriptomics Market Growth Rate Analysis
  • 5.4. Global RNA Analysis/ Transcriptomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global RNA Analysis/ Transcriptomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global RNA Analysis/ Transcriptomics Total Addressable Market (TAM)

6. RNA Analysis/ Transcriptomics Market Segmentation

  • 6.1. Global RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents/Consumables
  • Instruments
  • Software
  • 6.2. Global RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarrays
  • Sequencing
  • Polymerase Chain Reaction RNA Interference
  • 6.3. Global RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Diagnostics
  • Drug Discovery
  • Toxicogenomics
  • Comparative Transcriptomics
  • RNA Interference
  • 6.4. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Reagents/Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleotides
  • Enzymes
  • Buffers and Solutions
  • Sample Preparation Kits
  • Sequencing Kits
  • 6.5. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencers
  • Real-Time PCR Machines
  • Microarrays
  • Electrophoresis Systems
  • Robotic Liquid Handlers
  • 6.6. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Bioinformatics Tools
  • Statistical Analysis Software
  • Visualization Software
  • Database Management Systems

7. RNA Analysis/ Transcriptomics Market Regional And Country Analysis

  • 7.1. Global RNA Analysis/ Transcriptomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global RNA Analysis/ Transcriptomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific RNA Analysis/ Transcriptomics Market

  • 8.1. Asia-Pacific RNA Analysis/ Transcriptomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China RNA Analysis/ Transcriptomics Market

  • 9.1. China RNA Analysis/ Transcriptomics Market Overview
  • 9.2. China RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India RNA Analysis/ Transcriptomics Market

  • 10.1. India RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan RNA Analysis/ Transcriptomics Market

  • 11.1. Japan RNA Analysis/ Transcriptomics Market Overview
  • 11.2. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia RNA Analysis/ Transcriptomics Market

  • 12.1. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia RNA Analysis/ Transcriptomics Market

  • 13.1. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea RNA Analysis/ Transcriptomics Market

  • 14.1. South Korea RNA Analysis/ Transcriptomics Market Overview
  • 14.2. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe RNA Analysis/ Transcriptomics Market

  • 15.1. Western Europe RNA Analysis/ Transcriptomics Market Overview
  • 15.2. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK RNA Analysis/ Transcriptomics Market

  • 16.1. UK RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany RNA Analysis/ Transcriptomics Market

  • 17.1. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France RNA Analysis/ Transcriptomics Market

  • 18.1. France RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy RNA Analysis/ Transcriptomics Market

  • 19.1. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain RNA Analysis/ Transcriptomics Market

  • 20.1. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe RNA Analysis/ Transcriptomics Market

  • 21.1. Eastern Europe RNA Analysis/ Transcriptomics Market Overview
  • 21.2. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia RNA Analysis/ Transcriptomics Market

  • 22.1. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America RNA Analysis/ Transcriptomics Market

  • 23.1. North America RNA Analysis/ Transcriptomics Market Overview
  • 23.2. North America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA RNA Analysis/ Transcriptomics Market

  • 24.1. USA RNA Analysis/ Transcriptomics Market Overview
  • 24.2. USA RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada RNA Analysis/ Transcriptomics Market

  • 25.1. Canada RNA Analysis/ Transcriptomics Market Overview
  • 25.2. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America RNA Analysis/ Transcriptomics Market

  • 26.1. South America RNA Analysis/ Transcriptomics Market Overview
  • 26.2. South America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil RNA Analysis/ Transcriptomics Market

  • 27.1. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East RNA Analysis/ Transcriptomics Market

  • 28.1. Middle East RNA Analysis/ Transcriptomics Market Overview
  • 28.2. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa RNA Analysis/ Transcriptomics Market

  • 29.1. Africa RNA Analysis/ Transcriptomics Market Overview
  • 29.2. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. RNA Analysis/ Transcriptomics Market Competitive Landscape And Company Profiles

  • 30.1. RNA Analysis/ Transcriptomics Market Competitive Landscape
  • 30.2. RNA Analysis/ Transcriptomics Market Company Profiles
    • 30.2.1. Affymetrix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. RNA Analysis/ Transcriptomics Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. F. Hoffmann-La Roche Ltd.
  • 31.3. Sigma-Aldrich Corporation
  • 31.4. Thermo Fisher Scientific Inc.
  • 31.5. Fluidigm Corporation
  • 31.6. Promega Corporation
  • 31.7. bioMerieux S.A.
  • 31.8. CD Genomics Inc.
  • 31.9. Eurofins Scientific SE
  • 31.10. Merck KGaA
  • 31.11. Pacific Biosciences of California Inc.
  • 31.12. Danaher Corporation
  • 31.13. Genewiz Inc.
  • 31.14. Oxford Nanopore Technologies Ltd.
  • 31.15. BGI Group

32. Global RNA Analysis/ Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The RNA Analysis/ Transcriptomics Market

34. Recent Developments In The RNA Analysis/ Transcriptomics Market

35. RNA Analysis/ Transcriptomics Market High Potential Countries, Segments and Strategies

  • 35.1 RNA Analysis/ Transcriptomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 RNA Analysis/ Transcriptomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 RNA Analysis/ Transcriptomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer